Indications: Silymarin is indicated as adjunctive therapy in the
treatment of liver disease of varying etiologies; acute hepatitis, chronic
persistent and chronic aggressive hepatitis, cirrhosis of the liver, fatty
liver, toxic metabolic or toxic metabolic liver damage. It has been shown to
protect the liver from damage caused by general anesthesia.
